Table 2.
Resistance rates of Candida isolates to antifungals in invasive candidiasis episodes (presented as a number and rate of resistant isolates among total isolates tested for susceptibility).
| Candida spp. | Fluconazole n/N (%) |
Voriconazole n/N (%) |
Caspofungin n/N (%) |
Amphotericin B n/N (%) |
|---|---|---|---|---|
| Candida albicans | 1/57 (1.7) | 0/27 (0) | 0/26 (0) | 0/25 (0) |
| Candida parapsilosis | 1/22 (4.5) | 0/22 | 0/22 (0) | 1/22 (4.5) |
| Candida tropicalis | 1/17 (5.8) | 1/17 (5.8) | 0/17 (0) | 0/17 (0) |
| Nakaseomyces glabrata | 1/11 (10) | 1/10 (10) | 2/5 (40) | 0/11 (0) |
| Candida krusei | 6/6 (100) | 0/6 (0) | 4/6 (66.6) | 0/6 (0) |
| Others a | 6/19 (31.5) | 1/7 (14.2) | 0/4 (0) | NA a |
| Overall | 16/132 (12.1) | 3/89 (3.3) | 6/80 (7.5) | 1/80 (1.2) |
NA; not applicable. a No breakpoints available.